Home Radiofrequency Ablation of the Liver
Post
Cancel

Radiofrequency Ablation of the Liver

Rationale and Objectives

An in vitro perfused bovine liver model was used to evaluate the relationship between the sizes of radiofrequency ablation lesions and variation in portal venous blood flow.

Materials and Methods

Fourteen bovine livers were perfused with autologous heparinized blood at 37°C and 40% to 50% oxygenation via the portal vein. Flow rates were adjusted from 10 to 50 mL/min/100 g tissue. A 480-kHz generator and a 3.0-cm monopolar internally cooled electrode were used to create 57 ablations. The long-axis diameter, short-axis diameter (SAD), and volume of each ablation zone were measured and calculated from the dissected livers. Correlations between SAD, long-axis diameter, and volume versus blood flow were assessed using linear regression analysis.

Results

SAD and lesion volume demonstrated inverse linear correlations with blood flow (for SAD, y = −0.044 x + 3.925, r = 0.836, P < .001; for volume, y = −0.556 x + 31.574, r = 0.842, P < .001). A 10 mL/min/100 g change in flow rate produced an average 4.4 ± 0.4 mm change in SAD and an average 5.6 ± 0.5 cm 3 change in volume. Long-axis diameter was not correlated with blood flow ( y = −0.7694 x + 4.1899, r = 0.2173, P = .111).

Conclusions

The SAD and volume of radiofrequency ablation lesions have statistically significant inverse linear correlations with portal venous blood flow, with an average 4.4-mm change in SAD and an average 5.6-cm 3 change in volume for each 10 mL/min/100 g change in flow rate.

Percutaneous radiofrequency (RF) ablation is an accepted minimally invasive technique for the treatment of primary and secondary malignant hepatic tumors ; however, there is substantial variation in the reported success rate of local tumor eradication . Although multiple factors affect the success rate, unpredictable, marked variability in the size of the ablation zone produced by the same and different RF ablation devices is a major factor associated with local treatment failure . Not knowing the size of the coagulation necrosis that will be created by an RF ablation device prevents accurate treatment planning and increases the chance of an inadequate treatment.

It has been shown that variation in hepatic blood flow is the primary variable controlling the size of coagulation necrosis produced by RF ablation in the liver . Although multiple studies have shown that a reduction in hepatic blood flow is associated with an increase in the size of RF ablation zones, the experimental designs of previous studies did not allow analysis of direct incremental changes in hepatic blood flow on the size of RF ablation zones . A precise delineation of this relationship would add additional knowledge to the field, which could be useful for predicting the performance of RF ablation devices and enhancing RF ablation treatment planning.

Get Radiology Tree app to read full this article<

Materials and methods

Liver Procurement and Perfusion

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

RF Ablation Equipment

Get Radiology Tree app to read full this article<

Ablation Location and Technique

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Examination of the Ablation Specimens

Get Radiology Tree app to read full this article<

Statistical Analysis

Get Radiology Tree app to read full this article<

Results

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Table 1

Sizes of Radiofrequency Ablation Lesions in Different Lobes of Bovine Liver

Location Number of Ablations LAD (cm) SAD (cm) Volume (cm 3 ) RLA 25 4.0 ± 0.5 (3.0–46) 2.6 ± 0.5 (1.6–3.5) 15.0 ± 6.8 (4.8–28.8) LL 21 3.9 ± 0.3 (3.5–4.5) 2.8 ± 0.5 (1.7–3.6) 17.2 ± 6.5 (5.3–28.5) RLP 11 4.0 ± 0.3 (3.8–5.5) 2.8 ± 0.5 (1.7–3.5) 17.4 ± 7.2 (6.1–26.9)

LAD, long-axis diameter; LL, left lobe; RLA, right liver anterior; RLP, right liver posterior; SAD, short-axis diameter.

Data are expressed as mean ± standard deviation.

Figure 1, Regression plot showing a significant inverse correlation between radiofrequency ablation zone short-axis diameter and blood flow ( r = −0.836, P < .001).

Figure 2, Regression plot showing a significant inverse correlation between radiofrequency ablation zone volume and blood flow ( r = −0.842, P < .001).

Get Radiology Tree app to read full this article<

Discussion

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Get Radiology Tree app to read full this article<

Conclusions

Get Radiology Tree app to read full this article<

References

  • 1. Lencioni R., Crocetti L., Cioni D., et. al.: Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 2004; 39: pp. 689-697.

  • 2. Wong S.L., Mangu P.B., Choti M.A., et. al.: American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: pp. 493-508.

  • 3. Solbiati L., Ierace T., Goldberg S.N., et. al.: Percutaneous US-guided radio-frequency tissue ablation of liver metastases: long-term follow up. Radiology 1997; 202: pp. 195-203.

  • 4. Livraghi T., Goldberg S.N., Lazzaroni S., et. al.: Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: pp. 761-768.

  • 5. Hori T., Nagata K., Hasuike S., et. al.: Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38: pp. 977-981.

  • 6. Choi D., Lim H.K., Rhim H., et. al.: Percutaneous radiofrequency ablation for early stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: pp. 684-692.

  • 7. Lu D.S., Yu N.C., Raman S.S., et. al.: Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: pp. 954-960.

  • 8. Pereira P.L., Trubenbach J., Schenk M., et. al.: Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 2004; 232: pp. 482-490.

  • 9. de Baere T., Denys A., Wood B.J., et. al.: Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol 2001; 176: pp. 187-192.

  • 10. Montgomery R.S., Rahal A., Dodd G.D., et. al.: Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 2004; 182: pp. 657-661.

  • 11. Mulier S., Ni Y., Miao Y., et. al.: Size and geometry of hepatic radiofrequency lesions. Eur J Surg Oncol 2003; 29: pp. 867-878.

  • 12. Ahmed M., Liu Z., Humphries S., et. al.: Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2008; 24: pp. 577-588.

  • 13. Liu Z., Ahmed M., Sabir A., et. al.: Computer modeling of the effect of perfusion on heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2007; 23: pp. 49-58.

  • 14. Patterson E.J., Scudamore C.H., Owen D.A., et. al.: Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: pp. 559-565.

  • 15. Lu D.S., Raman S.S., Limanond P., et. al.: Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: pp. 1267-1274.

  • 16. Lu D.S., Raman S.S., Vodopich D.J., et. al.: Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178: pp. 47-51.

  • 17. de Baere T., Bessoud B., Dromain C., et. al.: Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002; 178: pp. 53-59.

  • 18. Washburn W.K., Dodd G.D., Kohlmeier R.E., et. al.: Radiofrequency tissue ablation: effect of hepatic blood flow occlusion on thermal injuries produced in cirrhotic livers. Ann Surg Oncol 2003; 10: pp. 773-777.

  • 19. Chinn S.B., Lee F.T., Kennedy G.D., et. al.: Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001; 176: pp. 789-795.

  • 20. Ritz J.P., Lehmann K., Isbert C., et. al.: Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion. Lasers Surg Med 2005; 36: pp. 238-244.

  • 21. Chang C.K., Hendy M.P., Smith J.M., et. al.: Radiofrequency ablation of the porcine liver with complete vascular occlusion. Ann Surg Oncol 2002; 9: pp. 594-598.

  • 22. Shen P., Fleming S., Westcott C., et. al.: Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver. J Surg Oncol 2003; 83: pp. 36-41.

  • 23. Wacker F.K., Reither K., Ritz J.P., et. al.: MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging 2001; 13: pp. 31-36.

  • 24. Iwamoto T., Kawai N., Sato M., et. al.: Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure. J Vasc Interv Radiol 2008; 19: pp. 1646-1651.

  • 25. Horigome H., Nomura T., Nakao H., et. al.: Half-deployed method: percutaneous radiofrequency ablation therapy using clustered electrodes for malignant liver tumors proximal to large vessels. AJR Am J Roentgenol 2001; 177: pp. 948.

  • 26. Goldberg S.N., Hahn P.F., Halpern E.F., et. al.: Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209: pp. 761-767.

  • 27. Orsi M.D., Dodd G.D., Cardan R.A., et. al.: In vitro blood perfused bovine liver model: a physiological model for evaluation of the performance of radiofrequency ablation devices. J Vasc Interv Radiol 2011; 22: pp. 1478-1483.

  • 28. Burns S.K., Dodd G.D., McManus L.M., et. al.: 3T magnetic resonance imaging accurately depicts radiofrequency ablation zones in a blood-perfused bovine liver model. J Vasc Interv Radiol 2012 Mar 27; [Epub ahead of print]

  • 29. Goldberg S.N., Gazelle G.S., Dawson S.L., et. al.: Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2: pp. 399-404.

  • 30. Ng K.K., Lam C.M., Poon R.T., et. al.: Porcine liver: morphologic characteristics and cell viability at experimental radiofrequency ablation with internally cooled electrodes. Radiology 2005; 235: pp. 478-486.

  • 31. Lubienski A., Bitsch R.G., Lubienski K., et. al.: Radiofrequency ablation (RFA): development of a flow model for bovine livers for extensive bench testing. Cardiovasc Intervent Radiol 2006; 29: pp. 1068-1072.

  • 32. Bitsch R.G., Düx M., Helmberger T., et. al.: Effects of vascular perfusion on coagulation size in radiofrequency ablation of ex vivo perfused bovine livers. Investigative Radiology 2006; 41: pp. 422-427.

  • 33. Sherriff S.B., Smart R.C., Taylor I.: Clinical study of liver blood flow in man measured by 133 Xe clearance after portal vein injection. Gut 1977; 18: pp. 1027-1031.

This post is licensed under CC BY 4.0 by the author.